Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nuo Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was -$2.45M. For fiscal 2025 it was -$1.14M. The highest annual figure on record is -$53.82K in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.14M | – |
| FY2024 | Dec 31, 2024 | -$2.39M | – |
| FY2023 | Dec 31, 2023 | -$3.18M | – |
| FY2022 | Dec 31, 2022 | -$3.77M | – |
| FY2021 | Dec 31, 2021 | -$119.96K | – |
| FY2020 | Dec 31, 2020 | -$53.82K | – |
| FY2019 | Dec 31, 2019 | -$921.67K | – |
| FY2015 | Dec 31, 2015 | -$15.09M | – |
| FY2014 | Dec 31, 2014 | -$17.91M | – |
| FY2013 | Dec 31, 2013 | -$12.15M | – |
| FY2011 | Dec 31, 2011 | -$4.31M | – |
| FY2010 | Dec 31, 2010 | -$4.31M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$489.50K | -287.8% |
| Q1 FY2026 | Mar 31, 2026 | -$785.12K | – |
| Q4 FY2025 | Dec 31, 2025 | -$465.85K | – |
| Q3 FY2025 | Sep 30, 2025 | -$706.52K | – |
| Q2 FY2025 | Jun 30, 2025 | $260.70K | – |
| Q1 FY2025 | Mar 31, 2025 | -$228.06K | – |
| Q4 FY2024 | Dec 31, 2024 | -$490.54K | – |
| Q3 FY2024 | Sep 30, 2024 | -$638.33K | – |
| Q2 FY2024 | Jun 30, 2024 | -$695.27K | – |
| Q1 FY2024 | Mar 31, 2024 | -$562.45K | – |
| Q4 FY2023 | Dec 31, 2023 | -$671.41K | – |
| Q3 FY2023 | Sep 30, 2023 | -$796.78K | – |
| Q2 FY2023 | Jun 30, 2023 | -$905.89K | – |
| Q1 FY2023 | Mar 31, 2023 | -$800.95K | – |
| Q4 FY2022 | Dec 31, 2022 | -$826.34K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.18M | – |
| Q1 FY2022 | Mar 31, 2022 | -$749.18K | – |
| Q4 FY2021 | Dec 31, 2021 | -$106.95K | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.16K | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.68K | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.17K | – |
| Q4 FY2020 | Dec 31, 2020 | -$33.57K | – |
See a number that looks wrong?